Hubei Longxiang Pharmaceutical Tech Co., Ltd. is a joint-stock and high-tech enterprise specialized in manufacturing and marketing veterinary pharmaceuticals, which is one of the top ten enterprises manufacturing veterinary APIs in China.It also focuses on finished products for veterinary use,intermediates ,contract manufacturing and contract research.GMP certified,has 14 API production lines and 2 preparation production lines, including florfenicol, tilmicosin, tilmicosin phosphate, valnemulin hydrochloride, toltrazuril, oxolinic acid APIs and finished products like florfenicol soluble powder, Tilmicosin enteric-coated granules.
more >
Year of Establishment:
2003
Total Assets(USD):
8,000,000 To 8,999,999
Total Number of Staff:
250 to 299
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Central/South America,Asia,Middle East
Other Competitive Advantages:
Patents and Copyrights: